Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

STRO US Equity

Sutro Biopharma, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1382101 · FY ends Dec 31
$21.91
-0.13 (-0.59%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by PERCEPTIVE ADVISORS LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Point72 Asset Management, L.P.sec.gov ↗
2026-08-128-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-3013GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-30

Every row is a filed document, checked against its EDGAR index.